The cell cycle pathway (CDKN2A/B, CDKN2C or RB1 genes) was also abnormal in 71% of patients (12/17) with Merkel cell carcinomas (Tables 1 and 2, Figure 1). The gene discussed is CDKN2C; the disease is Merkel cell skin cancer.